5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year.
International Stem Cell's 5-Year ROIIC % for the quarter that ended in Dec. 2023 was -126.96%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for International Stem Cell's 5-Year ROIIC % or its related term are showing as below:
ISCO's 5-Year ROIIC % is ranked worse than 72.82% of 1376
companies
in the Biotechnology industry
Industry Median: -18.965
vs ISCO: -126.96
International Stem Cell 5-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of International Stem Cell's 5-Year ROIIC %
For the Biotechnology subindustry, International Stem Cell's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
International Stem Cell's 5-Year ROIIC % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, International Stem Cell's 5-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where International Stem Cell's 5-Year ROIIC % falls into.
International Stem Cell 5-Year ROIIC % Calculation
International Stem Cell's 5-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:
5-Year ROIIC %
=
5-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
5-Year Incremental Invested Capital**
=
( -0.663 (Dec. 2023) - -3.474 (Dec. 2018) )
/
( 5.852 (Dec. 2023) - 8.066 (Dec. 2018) )
=
2.811
/
-2.214
=
-126.96%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
International Stem Cell (OTCPK:ISCO) 5-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
International Stem Cell 5-Year ROIIC % Related Terms
Thank you for viewing the detailed overview of International Stem Cell's 5-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.
International Stem Cell (International Stem Cell) Business Description
International Stem Cell Corp is a clinical-stage biotechnology company. It is focused on therapeutic and biomedical product development with multiple long-term therapeutic opportunities. The company develops different cell types from its stem cells that may result in therapeutic products. The clinical applications of the company include neural stem cells for the treatment of Parkinson's disease and other central nervous system disorders; Liver cells, which are used to treat a variety of congenital and acquired liver diseases; and retinal cells and three-dimensional eye structures. It operates in three segments, the therapeutic market, the biomedical market, and the anti-aging market. The Biomedical products business segment accounts for the majority of revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ISCO has been successfully added to your 